Part D Off-Label Coverage Should Not Be Limited To Compendia Lists – Lawsuit

Medicare Part D drug plans should be able to consider a variety of evidence supporting off-label uses of drugs, not just the standard medical compendia list of accepted indications, a lawsuit challenging HHS' interpretation of congressional directives on this issue argues